Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Gilead Sciences (NQ: GILD )

66.94 USD -0.04 (-0.06%)
Official Closing Price Updated: 7:59 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Gilead Sciences

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
3 Reasons This Hot Stock May Not Survive 2021
This promising cancer fighter might sell out this year to cash in on its potential. 
Tags SURF BMY GILD
From Motley Fool
3 Blockbuster Drug Launches to Watch This Year
These are the recently approved treatments biotech investors want to keep their eyes on in 2021. 
Tags PFE RHHBY BPMC
From Motley Fool
Better Buy: Gilead Sciences vs. Pfizer
One has a top COVID-19 treatment, the other has a top COVID-19 vaccine. Which stock will come out on top. 
Tags PFE GILD Market News
From Motley Fool
Gilead Sciences shares rise as Morgan Stanley upgrades its price target to $83
Tags features Market analysis Stocks & shares
From Invezz
Where Will Sorrento Therapeutics Be in 1 Year?
Can this biotech finally demonstrate progress in its COVID-19 pipeline before it's too late? 
Tags Market News SRNE GILD
From Motley Fool
Pfizer, GSK-Backed ViiV First To Get FDA Approval For HIV Shots: What You Need To Know
In a first, a monthly injectable HIV drug made by a GlaxoSmithKline plc (NYSE: GSK)- and Pfizer Inc (NYSE: PFE)-owned company has ... 
Tags HIV treatment PFE Benzinga
From Benzinga
Gilead Sciences to Release Fourth Quarter and Full Year 2020 Financial Results on Thursday, February 4, 2021
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its fourth quarter and full year 2020 financial results will be released on Thursday, February 4, after the market closes. At 4:30 p.m. Eastern... 
From Business Wire News Releases
Biden Stocks: 16 Stocks to Watch for a Defense Production Act Boost
<p><a rel="nofollow" href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>Biden stocks like APT stock, KODK stock, MMM stock and CAH stock are all... 
Tags HON OMI PFE
From InvestorPlace
GILD March 5th Options Begin Trading
Investors in Gilead Sciences Inc (GILD) saw new options begin trading today, for the March 5th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the GILD options chain... 
Tags Stocks
From Market News Video
3 Top Stocks for Retirees
Investors can buy and hold these stocks without losing sleep at night. 
Tags Market News ZM MA
From Motley Fool
My Best SaaS Stock for 2021
Veeva Systems could double its annual revenue over the next four years. 
Tags MRNA PFE Market News
From Motley Fool
2 High-Yield Dividend Stocks to Buy Now
Both stocks provide payouts that put the average stock on the S&P 500 to shame. 
Tags GILD PFE MRNA
From Motley Fool
Biopharma Leads Healthcare Portfolio 2020-2021
Clearly, biopharma stocks, both large and small, led the way to outperformance within healthcare. But Q4 2020 was very speculative, so we expect that the momentum will ebb in 2021 in a shift to... 
Tags Mutual Funds Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
Notable Tuesday Option Activity: GM, GILD, TWTR
Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in General Motors Co (GM), where a total of 445,846 contracts have traded so far, representing... 
Tags Stocks
From Market News Video
Gilead's 'Pivotal Year' — Why An Analyst Is Bullish Enough To Upgrade Shares
Gilead stock rocketed Tuesday after an analyst suggested 2021 would be a pivotal year as the biotech advances key medicines for HIV and breast cancer. 
From Investor's Business Daily
Why Gilead Sciences Stock Is Jumping Today
A Wall Street analyst upgraded the biotech stock. 
Tags Market News MRK GILD
From Motley Fool
The Gilead, Galapagos Pipeline Opportunities That Are Turning Morgan Stanley Bullish
Gilead Sciences, Inc. (NASDAQ: GILD) and its R&D partner Galapagos ADR Representing Ord Shs (NASDAQ: GLPG) received an upgrade each ... 
Tags Upgrades Benzinga GLPG
From Benzinga
Nasdaq 100 Movers: PTON, GILD
In early trading on Tuesday, shares of Gilead Sciences topped the list of the day's best performing components of the Nasdaq 100 index, trading up 5.1%. Year to date, Gilead Sciences registers a 14.2%... 
Tags Stocks
From Market News Video
Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2021
Upgrades For Wells Fargo & Co (NYSE:WFC), Seaport Global upgraded the previous rating of Neutral to Buy. Wells Fargo ... 
Tags GGG JBHT QSR
From Benzinga
Francesco M. Marincola Joins Kite as Worldwide Head of Cell Therapy Research
Kite, a Gilead Company (Nasdaq: GILD), today announced that Francesco Marincola, MD, will join the company as Senior Vice President and Global Head of Cell Therapy Research, effective February 1. Dr.... 
From Business Wire News Releases
3 Biotech Stocks To Watch This Week
Tags Market News
From Stockmarket.com
Gilead Stock 2021: Why The Biotech Stock Isn't Depending On Covid Drugs
Gilead Sciences isn't betting its 2021 on coronavirus treatment Veklury. But the biotech company still sees plenty of catalysts in oncology, virology and inflammation for Gilead stock. 
From Investor's Business Daily
IBB, AMGN, GILD, REGN: Large Inflows Detected at ETF
Symbols mentioned in this story: IBB, AMGN, GILD, REGN Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... 
Tags ETFs
From ETF Channel
Is Novavax's Growth Story Over?
The next few weeks could be critical for the biotech's coronavirus vaccine prospects. 
Tags Market News NVAX PFE
From Motley Fool
3 Top Biotech Picks for January
Buy these three biotech stocks before they take off. 
Tags Market News PFE AMGN
From Motley Fool
Is Gilead Sciences a Good Coronavirus Stock to Buy?
The biotech made headlines last year as the first to market a coronavirus treatment. What's in store for it in 2021? 
Tags Market News GILD
From Motley Fool
1 Big Reason Trillium Therapeutics Stock's Hot Streak Will Continue in 2021
When it comes to countering a key trick that cancer plays on the human immune system, this biotech has no equal. 
Tags TRIL GILD Market News
From Motley Fool
Why Vir Biotechnology Stock Vaulted Higher Today
The biotech announced updates about collaborations with two big partners. 
Tags GILD VIR GSK
From Motley Fool
Beigene Surges Closer To Breakout On $2.2 Billion Deal With Novartis
Beigene stock jumped Tuesday on a cancer drug development deal with Novartis worth up to $2.2 billion, as Vir Biotechnology also announced a hepatitis B tie-up with Gilead Sciences. 
From Investor's Business Daily
Gilead and Vir Biotechnology Establish Clinical Collaboration to Explore Combination Strategies for Functional Cure for Chronic Hepatitis B Virus
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.